Bull/Bear Index 47.5/100
→
SL Science (SLBT) Lists on Nasdaq Despite 35% Revenue Drop and Widening Losses... Betting on Cell Therapy
Key takeaway
"SL Science (SLBT) Lists on Nasdaq Despite 35% Revenue Drop and Widening Losses... Betting on Cell Therapy" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 50 out of 100. Reported by TokenPost on June 19, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 48.9%.
Join Telegram channel
or scan with phone →
